Sequential ablation of AKT1 in tobacco- and K-Ras-treated mice inhibits further lung tumor progression, and the same phenomenon has been observed in IGF-IR positive lung cancer [45,46]. The gene discussed is KRAS; the disease is lung carcinoma.